Stocks › Medical Devices › BBNX

Beta Bionics BBNX

US equityMarket cap rank #3400Medical Devices

$18.08 −$0.55 (-2.95%)

Pre-market · Oct 8, 8:10 am ET · After hours $18.08 0.00%

Open$18.91

Prev close$18.63

Day range$17.93 – $19.11

Volume1.53M

Market cap$813.41M

P/E (TTM)–

Dividend yield–

Earnings

Average move on report day±10.6%last 7 reports

Closed higher3 of 743% of the time

Best reaction+26.6%

Worst reaction-13.6%

Stock move on the day after each report

Quarter	Report date	Timing	Implied move	Actual move	Versus implied
2026/Q2	29 Jul 2026	After Market	±24.2%	-5.93%	Within range
2026/Q1	21 Apr 2026	After Market	±39.9%	-0.57%	Within range
2025/Q4	17 Feb 2026	After Market	±15.6%	-2.58%	Within range
2025/Q3	28 Oct 2025	After Market	–	+10.34%	–
2025/Q2	29 Jul 2025	After Market	–	+14.32%	–
2025/Q1	6 May 2025	After Market	–	+26.61%	–
2024/Q4	25 Mar 2025	After Market	–	-13.60%	–

"Implied move" is the size of move the options market was pricing ahead of the report. Move is the stock’s change on the first session after the release.

Where the revenue comes from

Quarter 2026/Q2

By business line

Single-use products$19.14M 59.8%
iLet$12.87M 40.2%

Fundamentals

Full statements →

Latest reported quarter: Q2, ended Jun 2026

Revenue$32.01M+37.8% YoY

Operating profit-$25.58M-28.7% YoY

Net profit-$23.40M-38.7% YoY

Diluted EPS-$0.53-35.9% YoY

Free cash flow-$15.66M-1.9% YoY

Operating cash flow-$14.62M

Revenue, last 8 quarters

Net profit, last 8 quarters

Profitability & balance sheet

Gross margin58.3%

Operating margin-69.8%

Net margin-61.3%

Return on equity-26.2%

Return on assets-23.5%

Return on invested capital-29.1%

Current ratio8.88

Liabilities / assets12.3%

Cash & investments$180.49M

Total debt$4.92M

Net cash (debt)$175.57M

Discussion

No comments yet — be the first to weigh in on BBNX.